FREE Consultation 844.948.6337 | Financing Available | Financial Assistance Available | NEW Wellness Services

Clinical Studies and other Resources

Categories

Select to view clinical studies and other resources

► A randomized placebo-controlled PET study of ketamine´s effect on serotonin1B receptor binding in patients with SSRI-resistant depression – Translational Psychiatry (June 2020)

► Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression - Journal of Affective Disorders (Nov. 2019)

► Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study - Journal of Child and Adolescent Psychopharmacology (July 2018)

► Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression – American Journal of Psychiatry (Dec 2017)

► World-First Ketamine Trial Shows Promise For Geriatric Depression – American Journal of Geriatric Psychiatry (July 2017)

► FDA Data Support Ketamine as Depression Therapy - MedPage Today (May 2017)

► Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial – Am J Psychiatry (Oct 2013)

► Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression – Biological Psychiatry (Aug 2013)

► Serial infusions of low-dose ketamine for major depression – Journal of Psychopharmacology (May 2013)

► Ketamine as a Novel Antidepressant: From Synapse to Behavior – Clinical Pharmacology & Therapeutics (Dec 2011)

 

► Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study - Journal of Psychopharmacology (Sept 2019)

► Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalized anxiety and social anxiety disorders - Journal of Psychopharmacology (March 2018)

► Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial - Neuropsychopharmacology (Jan 2018)

► Ketamine’s dose-related effects on anxiety symptoms in patients with treatment-refractory anxiety disorders – Journal of Psychopharmacology (April 2017)

 

► A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder – Am Journal of Psychiatry (Jan 2021)

► Effect of SGB Treatment on PTSD - JAMA (Nov 2019)

► New Promise for Treating PTSD - Psychology Today (August 2019)

► Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder - JAMA (June 2014)

► Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial – JAMA Psychiatry (June 2014)

► Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression - J Clin Psychiatry (May/June 2018)

► Ketamine As Treatment For Post-Traumatic Stress Disorder: A Review – NIH (April 2019)

► The Use of Ketamine Infusions for Refractory Headaches: A Retrospective Analysis – Am Society of Anesthesiologists (Oct 2017)

► Multi-day Low Dose Ketamine Infusion for the Treatment of Complex Regional Pain Syndrome – Pain Physician (April 2005)

► Subanesthetic Ketamine Infusion Therapy: A Retrospective Analysis of a Novel Therapeutic Approach to Complex Regional Pain Syndrome – Pain Medicine (Sept 2004)

► Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-Of-Concept - Neuropsychopharmacology (Nov 2013)